Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details)

v3.24.3
SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details) - GBP (£)
Jun. 30, 2024
Dec. 31, 2023
Payables and Accruals [Abstract]    
Accounts payable £ 942,267 £ 1,847,279
Other tax and social security 175,392 139,029
Accrued expenses 915,268 1,229,419
Amounts accrued in respect to clinical trial testing 1,177,500 1,177,500
Other payables 1,263 38,613
Total £ 3,211,690 £ 4,431,840